TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29205923

Group type: EXPERIMENTAL
Intervention: Home-based interval exercise training (12 weeks on a cycle ergometer)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Home-based interval exercise training
Number of subjects: 26
Study: 26312614

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 19
Study: 24465561

Group type: EXPERIMENTAL
Intervention: Quiz-module with competition widgets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Quiz-module without competition widgets
Number of subjects: 0
Study: 23662512

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy
Number of subjects: 162
Study: 20649501

Group type: EXPERIMENTAL
Intervention: Benidipine (2 mg/day increased to 8 mg/day)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Cilnidipine (5 mg/day increased to 20 mg/day)
Number of subjects: 233
Study: 17704024

Group type: EXPERIMENTAL
Intervention: Low lactose infant formula supplemented with added precooked rice (1.5 g/100mL) with probiotic, prebiotic, fiber and increased amounts of zinc+iron
Number of subjects: 58

Group type: COMPARATOR
Intervention: Low lactose infant formula with added precooked rice without the above active ingredient supplement
Number of subjects: 58
Study: 15846251

Group type: EXPERIMENTAL
Intervention: GRD 180 mg evening dose
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: GRD 360 mg evening dose
Number of subjects: 311

Group type: COMPARATOR
Intervention: GRD 360 mg morning dose
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: GRD 420 mg evening dose
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: GRD 360 mg evening dose vs GRD 360 mg morning dose
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: All GRD doses
Number of subjects: 311
Study: 11768028

Group type: EXPERIMENTAL
Intervention: Granisetron 2 mg
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study: 9258843

Group type: EXPERIMENTAL
Intervention: 'do your best'
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 'improve by 10%' (easy)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 'improve by 20%' (difficult/realistic)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 'improve by 40%' (improbable/unattainable)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 4 weeks practice duration
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 6 weeks practice duration
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 8 weeks practice duration
Number of subjects: 15
Study: 8251920

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) treatment
Number of subjects: 230

Group type: COMPARATOR
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 230
Study: 3645177

Group type: EXPERIMENTAL
Intervention: Educational sessions designed to teach students various aspects of oral health
Number of subjects: 92

Group type: COMPARATOR
Intervention: Oral examination control (Group one)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Full series of self-care motivation curriculum sessions (Group five)
Number of subjects: 92
Study: 2551359

Group type: EXPERIMENTAL
Intervention: Maintenance therapy (CVM for 6 cycles)
Number of subjects: 68

Group type: COMPARATOR
Intervention: No maintenance therapy (NM)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Maintenance therapy (CVM for 6 cycles) among patients in complete remission
Number of subjects: 68

Group type: COMPARATOR
Intervention: No maintenance therapy (NM) among patients in complete remission
Number of subjects: 68
Study: 31752508

Group type: EXPERIMENTAL
Intervention: Interpersonal and social rhythm therapy (IPSRT)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Interpersonal and social rhythm therapy (IPSRT) with cognitive remediation
Number of subjects: 11
Study: 30874292

Group type: EXPERIMENTAL
Intervention: Polylactic membrane (PLM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrofiber dressing with silver (HFAg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (normal children)
Number of subjects: 0
Study: 28701300

Group type: EXPERIMENTAL
Intervention: Glucose infusion to the ileum (15 g, 235 kJ)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Glucose infusion to the duodenum (15 g, 235 kJ)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline infusion to the ileum
Number of subjects: 14

Group type: COMPARATOR
Intervention: Saline infusion to the duodenum
Number of subjects: 14
Study: 25088240

Group type: EXPERIMENTAL
Intervention: Distal locking Gamma 3 nail
Number of subjects: 177

Group type: COMPARATOR
Intervention: Standard Gamma nail without distal locking
Number of subjects: 177
Study: 24263289

Group type: EXPERIMENTAL
Intervention: Motivational tone content
Number of subjects: 1865

Group type: COMPARATOR
Intervention: Prescriptive tone content
Number of subjects: 1865

Group type: EXPERIMENTAL
Intervention: Multiple imputations accounting for time-outs
Number of subjects: 1865
Study: 21257979

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 149

Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 149
Study: 17993283

Group type: EXPERIMENTAL
Intervention: Risedronate (5 mg/day, 35 mg/week, 50 mg/week, 15 mg/day)
Number of subjects: 1885

Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 1885

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1885
Study: 17056774

Group type: EXPERIMENTAL
Intervention: Five behavioral counseling (BC) sessions
Number of subjects: 46

Group type: COMPARATOR
Intervention: One behavioral counseling (BC) session
Number of subjects: 46
Study: 15541915

Group type: EXPERIMENTAL
Intervention: Salbutamol delivered by dry powder inhaler (400 to 1600 microg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Salbutamol delivered by dry powder inhaler (1600 microg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cascade impactor analysis (MSLI and ACI)
Number of subjects: 6
Study: 11523499

Group type: EXPERIMENTAL
Intervention: Wellness-Based Mindfulness Stress Reduction intervention
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (educational materials and community resources)
Number of subjects: 103
Study: 9249640

Group type: EXPERIMENTAL
Intervention: Bioabsorbable demineralized laminar bone allograft membrane
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-resorbable expanded polytetrafluoroethylene (ePTFE) membrane
Number of subjects: 12
Study: 8518603

Group type: EXPERIMENTAL
Intervention: Antiepileptic drug withdrawal
Number of subjects: 1013

Group type: COMPARATOR
Intervention: Continued antiepileptic drug treatment
Number of subjects: 1013
Study: 3031574

Group type: EXPERIMENTAL
Intervention: RIT 4237 bovine rotavirus vaccine
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study: 31096264

Group type: EXPERIMENTAL
Intervention: THC (one pill, administered 2 hours before threat extinction learning)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PBO, administered 2 hours before threat extinction learning)
Number of subjects: 0
Study: 29183339

Group type: EXPERIMENTAL
Intervention: EMG-triggered NMES with bilateral arm training
Number of subjects: 38

Group type: COMPARATOR
Intervention: TENS with bilateral arm training
Number of subjects: 38
Study: 25950418

Group type: EXPERIMENTAL
Intervention: Daily oropharyngeal exercises
Number of subjects: 39

Group type: COMPARATOR
Intervention: Nasal dilator strips plus respiratory exercises (control)
Number of subjects: 39
Study: 22728314

Group type: EXPERIMENTAL
Intervention: 100 mg of caffeine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 20
Study: 21224837

Group type: EXPERIMENTAL
Intervention: Gluten (two bread slices plus one muffin per day for up to 6 weeks)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Gluten
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 19614944

Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg/day
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study: 16438766

Group type: EXPERIMENTAL
Intervention: Internet-based CPR-D course
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Traditional small-group CPR-D course
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no specific training in CPR-D)
Number of subjects: 56
Study: 12852841

Group type: EXPERIMENTAL
Intervention: Loratadine (LOR) 20 mg
Number of subjects: 20
Study: 11391146

Group type: COMPARATOR
Intervention: Closed hemorrhoidectomy with electrocautery
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Harmonic Scalpel hemorrhoidectomy
Number of subjects: 30
Study: 9141231

Group type: EXPERIMENTAL
Intervention: 75 mg atenolol per day (beta-blocker group)
Number of subjects: 25

Group type: COMPARATOR
Intervention: 40 mg fosinopril per day alone (control group)
Number of subjects: 25
Study: 7506156

Group type: EXPERIMENTAL
Intervention: Nimesulide 100mg twice daily for three 10-day cycles
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Nimesulide 200mg twice daily via rectal route
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ketoprofen 100mg twice daily via rectal route
Number of subjects: 70
Study: 2962418

Group type: EXPERIMENTAL
Intervention: 0.5 mg 17 beta‐estradiol cyclo‐octyl acetate (E2COA) and 0.15 mg desogestrel for 21 days, followed by 0.03 mg desogestrel for an additional 7 days in half the group
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.03 mg desogestrel added during the fourth investigation week
Number of subjects: 10
Study: 31992331

Group type: EXPERIMENTAL
Intervention: Ultrasonic subgingival scaling combined with manual root planing
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ultrasonic subgingival debridement
Number of subjects: 40
Study: 31386610

Group type: EXPERIMENTAL
Intervention: Cediranib with platinum-pemetrexed
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo with platinum-pemetrexed
Number of subjects: 92
Study: 28778747

Group type: EXPERIMENTAL
Intervention: HIGH load (2×10‐15 repetitions at 80% of one‐repetition maximum (1‐RM))
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: LOW load (1×80‐100 repetitions at 20% of 1‐RM)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: LOW+ load (1×60 repetitions at 20% of 1‐RM, followed by 1×10‐20 repetitions at 40% 1‐RM)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Detraining (after 24 weeks)
Number of subjects: 56
Study: 25261956

Group type: EXPERIMENTAL
Intervention: Microdebrider surgery
Number of subjects: 26

Group type: COMPARATOR
Intervention: CO2 laser surgery
Number of subjects: 26
Study: 23279307

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 584

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 584

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 584
Study: 21195195

Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 18492834

Group type: EXPERIMENTAL
Intervention: Fish oil capsules (5 mL/d, mean intake 3.1 g/d (n‐3) LCPUFA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Olive oil capsules (control)
Number of subjects: 64
Study: 17138310

Group type: EXPERIMENTAL
Intervention: Moderate pressure massage therapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Light pressure massage therapy
Number of subjects: 68
Study: 14578244

Group type: EXPERIMENTAL
Intervention: Insulin detemir (0.5 units/kg s.c.)
Number of subjects: 34

Group type: COMPARATOR
Intervention: NPH insulin (0.5 IU/kg)
Number of subjects: 34
Study: 10761170

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg daily for 12 weeks
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 34
Study: 8817416

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reduced dose radiotherapy with chemotherapy
Number of subjects: 0
Study: 1386691

Group type: EXPERIMENTAL
Intervention: Methacholine inhalation (causing a nearly 20% fall in FEV1)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Procaterol (30 micrograms)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 22
Study: 6405435

Group type: EXPERIMENTAL
Intervention: d‐Amp (10 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: d‐Amp (20 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 30703100

Group type: EXPERIMENTAL
Intervention: Higher BMI (1 kg/m2 increase)
Number of subjects: 396495

Group type: COMPARATOR
Intervention: Psoriasis genetic risk
Number of subjects: 396495
Study: 30253916

Group type: EXPERIMENTAL
Intervention: Mastery learning
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional learning
Number of subjects: 40
Study: 26095261

Group type: EXPERIMENTAL
Intervention: Toric intraocular lens (IOL) implantation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Monofocal IOL implantation followed by PRK
Number of subjects: 52
Study: 23384731

Group type: EXPERIMENTAL
Intervention: Lidocaine 0.93% w/v
Number of subjects: 52
Study: 20847729

Group type: EXPERIMENTAL
Intervention: Higher Protein (HP, 25% of energy as protein, n = 14)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 3 eating occasions/day (3-EO) within HP group
Number of subjects: 27

Group type: COMPARATOR
Intervention: Normal Protein (NP, 14% of energy as protein, n = 13)
Number of subjects: 27
Study: 19262964

Group type: EXPERIMENTAL
Intervention: Non-pharmacological strategies for treating BPSD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 17355644

Group type: EXPERIMENTAL
Intervention: Pre-discharge home visit by occupational therapist
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard practice in-hospital assessment and education
Number of subjects: 10
Study: 15297952

Group type: EXPERIMENTAL
Intervention: Foot and hand massage (20 minutes, 5 minutes to each extremity) provided 1 to 4 hours after pain medication
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Foot and hand massage
Number of subjects: 18
Study: 12144221

Group type: EXPERIMENTAL
Intervention: Traditional phototherapy 23 hours per day and for the 24th hour were given KMC with a fiberoptic phototherapy panel held against their back
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional phototherapy 23 hours per day and for the 24th hour lay prone on a fiberoptic phototherapy panel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Traditional bank or spotlight phototherapy 24 hours per day
Number of subjects: 30
Study: 9566646

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg day[-1])
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg day[-1]) + omega-3 fatty acids (4 g day[-1])
Number of subjects: 41

Group type: COMPARATOR
Intervention: omega-3 fatty acids (4 g day[-1])
Number of subjects: 41
Study: 9360002

Group type: EXPERIMENTAL
Intervention: Lisinopril (20 mg once a day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 2037324

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine administered intrapleurally
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 120
Study: 6971108

Group type: EXPERIMENTAL
Intervention: Tiaprofenic acid
Number of subjects: 7

Group type: COMPARATOR
Intervention: Aluminum hydroxide
Number of subjects: 7

Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 7
Study: 31543428

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks for 24 weeks (SINUS-24)
Number of subjects: 724

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks for 52 weeks (SINUS-52)
Number of subjects: 724

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 724
Study: 28380277

Group type: EXPERIMENTAL
Intervention: FoF cue (reactivation group)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Neutral cue (control group)
Number of subjects: 89
Study: 26799118

Group type: EXPERIMENTAL
Intervention: Cervical total disc replacement (TDR)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 599
Study: 24631095

Group type: EXPERIMENTAL
Intervention: JE-CV and MMR vaccines administered concomitantly (Group 'Co-Ad')
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: MMR vaccine administered separately after JE-CV (Group 'MMR')
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: JE-CV vaccine administered separately before MMR (Group 'JE-CV')
Number of subjects: 550

Group type: COMPARATOR
Intervention: JE-CV and MMR vaccines administered separately 6 weeks apart (Groups 'JE-CV' and 'MMR')
Number of subjects: 550
Study: 22691917

Group type: EXPERIMENTAL
Intervention: IV-administered acetaminophen 30 mg/kg, administered at the end of surgery and thereafter twice at 8-hour intervals
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: IV-administered acetaminophen 30 mg/kg
Number of subjects: 36
Study: 19585478

Group type: EXPERIMENTAL
Intervention: Spearmint tea (twice a day for 30 days)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo herbal tea
Number of subjects: 42
Study: 17852793

Group type: EXPERIMENTAL
Intervention: ECC.O
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard CPB
Number of subjects: 40
Study: 15956938

Group type: EXPERIMENTAL
Intervention: Patching regimen recommendations from the randomized trial
Number of subjects: 90
Study: 12392809

Group type: EXPERIMENTAL
Intervention: Increased social support from friends
Number of subjects: 187

Group type: COMPARATOR
Intervention: Substance-using friends or partners
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: Older age, lower heroin use frequency, lower cocaine use, and increased frequency of needle exchange visits
Number of subjects: 187
Study: 9767554

Group type: EXPERIMENTAL
Intervention: 2 mg daily of oral, micronized estradiol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 7893848

Group type: EXPERIMENTAL
Intervention: Sleep Deprivation (SD)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Undisturbed Sleep (US)
Number of subjects: 11
Study: 3148355

Group type: EXPERIMENTAL
Intervention: Transdermal glyceryl trinitrate
Number of subjects: 340

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 340
Study: 30927124

Group type: EXPERIMENTAL
Intervention: Hemospray (TC-325) with epinephrine injection
Number of subjects: 39

Group type: COMPARATOR
Intervention: Hemoclip with epinephrine injection
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Hemospray (TC-325)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Hemoclip
Number of subjects: 39
Study: 29214353

Group type: EXPERIMENTAL
Intervention: Complete bladder neck preservation (cBNP)
Number of subjects: 199

Group type: COMPARATOR
Intervention: No bladder neck preservation (noBNP)
Number of subjects: 199
Study: 27782887

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg
Number of subjects: 41

Group type: COMPARATOR
Intervention: Pantoprazole 40 mg
Number of subjects: 41
Study: 25238615

Group type: EXPERIMENTAL
Intervention: Risk homozygotes (rs267734 variant)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Heterozygotes (rs267734 variant)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Non-risk homozygotes (rs267734 variant)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Risk allele presence
Number of subjects: 100
Study: 22210362

Group type: EXPERIMENTAL
Intervention: Bright light therapy for 1 hour
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo dim red light for 1 hour
Number of subjects: 0
Study: 20810251

Group type: EXPERIMENTAL
Intervention: Statistical Process Control (SPC) charts
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Drug increase
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Drug interventions identified by epileptologists
Number of subjects: 38
Study: 18256392

Group type: EXPERIMENTAL
Intervention: Prospective HLA-B*5701 screening
Number of subjects: 1956

Group type: COMPARATOR
Intervention: Standard-of-care approach (control group)
Number of subjects: 1956
Study: 15964564

Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg, n=16)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (n=8)
Number of subjects: 24
Study: 12060155

Group type: EXPERIMENTAL
Intervention: Digital radiography
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional radiography
Number of subjects: 60
Study: 10482259

Group type: EXPERIMENTAL
Intervention: Campath‐1H monoclonal antibody treatment
Number of subjects: 27
Study: 8760782

Group type: EXPERIMENTAL
Intervention: Mometasone furoate, 200 micrograms once daily
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate, 200 micrograms twice daily (400 micrograms total dose)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Placebo vehicle control
Number of subjects: 427
Study: 1496505

Group type: EXPERIMENTAL
Intervention: Carbohydrate rich drink
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fat rich drink
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-calorific control drink
Number of subjects: 10
Study: 6388612

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 14
Study: 31384292

Group type: EXPERIMENTAL
Intervention: Operative fixation (open reduction and internal fixation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonoperative treatment (pain management, bronchodilator inhalers, oxygen support, mechanical ventilation if needed, pulmonary physical therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Operative fixation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 0
Study: 29374233

Group type: EXPERIMENTAL
Intervention: Gene variants associated with longer leukocyte telomere length (LTL) in the TERT gene
Number of subjects: 9907

Group type: EXPERIMENTAL
Intervention: Experimental hTERT-expression in primary human fibroblasts
Number of subjects: 9907
Study: 25683094

Group type: EXPERIMENTAL
Intervention: Oral salt supplementation (113 mmol Na(+) and 112 mmol Cl(‐))
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (cellulose)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Oral salt supplementation
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26